Serum concentrations of androstenediol and androstenediol sulfate, and their relation to cytokine production during and after normal pregnancy

Abstract

Since it is known that androstenediol (ADIOL) has potent immunoregulatory effects, changes in ADIOL levels during and after pregnancy might affect the maternal immune system. We examined serum concentrations of ADIOL and androstenediol 3-sulfate (ADIOLS) together with IFN-γ and IL-4 production levels during pregnancy and after delivery up to 10–11 months postpartum. The subjects were 73 normal pregnant, 76 normal postpartum, and 28 normal non-pregnant women. ADIOL and ADIOLS were measured using EIA and GC/MS, respectively. The cytokine levels in the supernatant of whole-blood cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin were measured using ELISA. ADIOL levels significantly decreased compared to non-pregnant levels in the first trimester ( P < 0.05) and were reversed in the third trimester ( P < 0.05). After pregnancy, ADIOL levels gradually declined, and a significant decrease was observed at 10–11 months postpartum ( P < 0.05). ADIOLS levels were significantly lower in the third trimester ( P < 0.05) and significantly higher at the first month postpartum ( P < 0.001) compared to non-pregnant women. IFN-γ and IL-4 levels decreased during pregnancy and subsequently increased postpartum. On the other hand, we found significant negative correlations between ADIOL concentrations and production levels of IFN-γ ( P < 0.05) or IL-4 ( P < 0.05). These findings suggest that ADIOL may be involved in modifying the maternal immune response during and after pregnancy.